These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 14597926)

  • 1. Percutaneous coronary intervention: historical perspectives, current status, and future directions.
    Arjomand H; Turi ZG; McCormick D; Goldberg S
    Am Heart J; 2003 Nov; 146(5):787-96. PubMed ID: 14597926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents: a pharmacoclinical perspective.
    Thomas MK; Gupta YK
    Natl Med J India; 2006; 19(4):195-9. PubMed ID: 17100106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Restenosis related to percutaneous coronary intervention has been solved?
    Kivelä A; Hartikainen J
    Ann Med; 2006; 38(3):173-87. PubMed ID: 16720432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-eluting stent safety.
    Slottow TL; Waksman R
    Am J Cardiol; 2007 Oct; 100(8B):10M-17M. PubMed ID: 17950827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents.
    Doyle B; Rihal CS; O'Sullivan CJ; Lennon RJ; Wiste HJ; Bell M; Bresnahan J; Holmes DR
    Circulation; 2007 Nov; 116(21):2391-8. PubMed ID: 17984377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coronary artery stents: Part I. Evolution of percutaneous coronary intervention.
    Newsome LT; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):552-69. PubMed ID: 18633035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covered stents: a review.
    Jamshidi P; Mahmoody K; Erne P
    Int J Cardiol; 2008 Nov; 130(3):310-8. PubMed ID: 18672301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-eluting coronary stents: many meta-analyses, little benefit.
    Prescrire Int; 2009 Apr; 18(100):70-4. PubMed ID: 19585727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stent thrombosis in the era of drug eluting stents.
    Kawaguchi R; Angiolillo DJ; Futamatsu H; Suzuki N; Bass TA; Costa MA
    Minerva Cardioangiol; 2007 Apr; 55(2):199-211. PubMed ID: 17342038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Optimal platelet inhibition after coronary stent implantation. Current status].
    Silber S; Hoffmeister HM; Bode C
    Herz; 2008 Jun; 33(4):244-53. PubMed ID: 18581073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.
    Al Suwaidi J; Holmes DR; Salam AM; Lennon R; Berger PB
    Am Heart J; 2004 May; 147(5):815-22. PubMed ID: 15131536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Off-label use of drug-eluting stents putting it in perspective.
    Grines CL
    J Am Coll Cardiol; 2008 Feb; 51(6):615-7. PubMed ID: 18261679
    [No Abstract]   [Full Text] [Related]  

  • 13. Antiplatelet therapy in the era of drug-eluting stents: current and future perspectives.
    Ducrocq G; Serebruany V; Tanguay JF
    Expert Rev Cardiovasc Ther; 2007 Sep; 5(5):939-53. PubMed ID: 17867923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjunctive balloon postdilatation after stent deployment: is it still necessary with drug-eluting stents?
    Brodie BR
    J Interv Cardiol; 2006 Feb; 19(1):43-50. PubMed ID: 16483339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular brachytherapy: applications in the era of drug-eluting stents.
    Waksman R
    Rev Cardiovasc Med; 2002; 3 Suppl 5():S23-30. PubMed ID: 12478232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Late stent thrombosis with drug-eluting stents: the price to pay to prevent restenosis?
    Kumbhani DJ; Bavry AA; Bhatt DL
    Indian Heart J; 2007; 59(2 Suppl B):B113-7. PubMed ID: 19153427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
    Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term safety and efficacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry.
    Marzocchi A; Saia F; Piovaccari G; Manari A; Aurier E; Benassi A; Cremonesi A; Percoco G; Varani E; Magnavacchi P; Guastaroba P; Grilli R; Maresta A
    Circulation; 2007 Jun; 115(25):3181-8. PubMed ID: 17562952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment and prevention of restenosis after percutaneous coronary intervention. Balloons, stents, radioactive rays and drug-releasing stents].
    Maeng M; Thuesen L; Andersen HR
    Ugeskr Laeger; 2005 Aug; 167(33):3030-2. PubMed ID: 16109244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coronary artery stents: II. Perioperative considerations and management.
    Newsome LT; Weller RS; Gerancher JC; Kutcher MA; Royster RL
    Anesth Analg; 2008 Aug; 107(2):570-90. PubMed ID: 18633036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.